| FDDTX | RBDTX | FDDTX / RBDTX | |
| Total Expense Ratio | 0.31 | 1.40 | 22% |
| Annual Report Gross Expense Ratio | 0.31 | 1.40 | 22% |
| Fund Existence | 9 years | 19 years | - |
| Gain YTD | 14.616 | 13.433 | 109% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 250 | 400,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 32.3B | 32.3B | 100% |
| Annual Yield % from dividends | 2.51 | 1.59 | 158% |
| Returns for 1 year | 9.68 | 8.39 | 115% |
| Returns for 3 years | 29.57 | 25.95 | 114% |
| Returns for 5 years | 19.99 | 14.51 | 138% |
| Returns for 10 years | N/A | 48.78 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SGDJ | 89.05 | 2.83 | +3.28% |
| Sprott Junior Gold Miners ETF | |||
| YGLD | 43.69 | 0.62 | +1.44% |
| Simplify Gold Strategy PLUS Income ETF | |||
| RQI | 11.39 | -0.01 | -0.09% |
| COHEN & STEERS QUALITY Income REALTY FUND | |||
| KEMX | 37.43 | -0.17 | -0.44% |
| KraneShares MSCI Em Mkts ex CHN ETF | |||
| BIS | 9.50 | -0.15 | -1.53% |
| ProShares UltraShort Nasdaq Biotech | |||